Accuracy of endoscopic ultrasound-guided fine-needle aspiration in the suspicion of pancreatic metastases


Autoria(s): Ardengh, José Celso ; Lopes, César Vivian ; Kemp, Rafael; Venco, Filadélfio ; Lima-Filho, Eder Rios de; Santos, José Sebastião dos
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

14/10/2013

14/10/2013

2013

Resumo

Abstract Background Metastases to the pancreas are rare, and usually mistaken for primary pancreatic cancers. This study aimed to describe the histology results of solid pancreatic tumours obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for diagnosis of metastases to the pancreas. Methods In a retrospective review, patients with pancreatic solid tumours and history of previous extrapancreatic cancer underwent EUS-FNA from January/1997 to December/2010. Most patients were followed-up until death and some of them were still alive at the end of the study. The performance of EUS-FNA for diagnosis of pancreatic metastases was analyzed. Symptoms, time frame between primary tumour diagnosis and the finding of metastases, and survival after diagnosis were also analyzed. Results 37 patients underwent EUS-FNA for probable pancreas metastases. Most cases (65%) presented with symptoms, especially upper abdominal pain (46%). Median time between detection of the first tumour and the finding of pancreatic metastases was 36 months. Metastases were confirmed in 32 (1.6%) cases, 30 of them by EUS-FNA, and 2 by surgery. Other 5 cases were non-metastatic. Most metastases were from lymphoma, colon, lung, and kidney. Twelve (32%) patients were submitted to surgery. Median survival after diagnosis of pancreatic metastases was 9 months, with no difference of survival between surgical and non-surgical cases. Sensitivity, specificity, positive and negative predictive values, and accuracy of EUS-FNA with histology analysis of the specimens for diagnosis of pancreatic metastases were, respectively, 93.8%, 60%, 93.8%, 60% and 89%. Conclusion EUS-FNA with histology of the specimens is a sensitive and accurate method for definitive diagnosis of metastatic disease in patients with a previous history of extrapancreatic malignancies.

The authors are in debt with the Foundation Waldemar Barmley Pessoa, which was responsible for the acquisition of the needles for the patients of this study.

Identificador

BMC Gastroenterology, London, v.13, n.63, p. 1-7, 2013

1471-230X

http://www.producao.usp.br/handle/BDPI/34651

10.1186/1471-230X-13-63

10.1186/1471-230X-13-63

http://www.biomedcentral.com/1471-230X/13/63

Idioma(s)

eng

Publicador

London

Relação

BMC Gastroenterology

Direitos

openAccess

Ardengh et al.; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Palavras-Chave #Pancreatic neoplasms #Metastasis #Endosonography #Biopsy #Fine-needle #Histology
Tipo

article